Standard Biotools | FLDM - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Agilent USD 946M 44M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Bio-Rad Laboratories USD 343.4M 1.9M 2025-09
Bruker USD 449.2M 69.8M 2025-12
Danaher USD 3.97B 443M 2025-12
Illumina USD 759M 26M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
Nikon Corporation JPY 67.21B 14.78B 2025-06
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Revvity USD 421.66M 47.06M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sony JPY 1.01T 160.99B 2025-09
Standard Biotools USD 11.38M 1.9M 2025-12
Thermo Fisher Scientific USD 4.64B 419M 2025-12
Waters USD 557.42M 97.44M 2025-12